POLARIS INSIGHTS

Billionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run?

Revolution Medicines (NASDAQ: RVMD) has been one of the hottest biotech stocks this year.

More from the Markets desk